The German Genomics Initiative - genomDE

Genomic data in combination with clinical data will enable the provision of novel healthcare services and products, which are individualized (personalized medicine). In addition, genomic data contain valuable information for the research and development of personalized drugs.

Rolling out genomics into healthcare will open up opportunities to study the genetic and molecular components of health and disease on an unprecedented scale once ethical and regulatory, technical, societal and security challenges are taken care of.

Last change: 06. December 2021
Please note
Dear Sir or Madam, unfortunately you are using a browser version that is no longer supported by the Federal Ministry of Health. In order to use the offer and all functions in full reception, please update your browser to the latest version of Chrome, Firefox, Safari or Edge. For security reasons, Internet Explorer is not supported.